Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.91 USD
Change Today +0.34 / 4.49%
Volume 5.1M
ARIA On Other Exchanges
As of 12:28 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Harvey J. Berger M.D.

Principal Founder, Chairman, Chief Executive Officer and President,Ariad Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Harvey J. Berger, M.D. is the Principal founder of Ariad Pharmaceuticals Inc. and has been its Chairman and Chief Executive Officer since April 1991 and also has been its President since December 17, 2004. Previously, Dr. Berger served as President of Ariad Pharmaceuticals Inc. from April 1991 to 2003. From 1986 to 1991, he held a series of senior management positions at Centocor, Inc., a biotechnology company, including Executive Vice President and President, Research ...

Read Full Background

Corporate Headquarters*

26 Landsdowne Street
Cambridge, Massachusetts 02139

United States

Phone: 617-494-0400
Fax: 617-494-8144

Board Members Memberships*

Principal Founder, Chairman, Chief Executive Officer and President


Unknown/Other Education
The General Hospital Corporation
Colgate University
Yale University School Of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,389,350

Stock Options*

Restricted Stock Awards$1,928,790
All Other Compensation$42,560
Exercised Options150,000
Exercised Options Value$78,000
Exercisable Options849,000
Exercisable Options Value$594,700
Unexercisable Options215,000
Total Value of Options$672,700
Total Number of Options1,214,000

Total Compensation*

Total Annual Cash Compensation$1,431,910
Total Short Term Compensation$1,389,350
Other Long Term Compensation$1,971,350
Total Calculated Compensation$3,360,700
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARIA:US $7.91 USD +0.34


Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
Aijaz Tobaccowalla Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee
Pfizer Limited
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at